Literature DB >> 25722252

Synchronous systolic subcellular Ca2+-elevations underlie ventricular arrhythmia in drug-induced long QT type 2.

Jong J Kim1, Jan Němec1, Qiao Li1, Guy Salama2.   

Abstract

BACKGROUND: Repolarization delay is a common clinical problem, which can promote ventricular arrhythmias. In myocytes, abnormal sarcoplasmic reticulum Ca(2+)-release is proposed as the mechanism that causes early afterdepolarizations, the cellular equivalent of ectopic-activity in drug-induced long-QT syndrome. A crucial missing link is how such a stochastic process can overcome the source-sink mismatch to depolarize sufficient ventricular tissue to initiate arrhythmias. METHODS AND
RESULTS: Optical maps of action potentials and Ca(2+)-transients from Langendorff rabbit hearts were measured at low (150×150 μm(2)/pixel) and high (1.5×1.5 μm(2)/pixel) resolution before and during arrhythmias. Drug-induced long QT type 2, elicited with dofetilide inhibition of IKr (the rapid component of rectifying K+ current), produced spontaneous Ca(2+)-elevations during diastole and systole, before the onset of arrhythmias. Diastolic Ca(2+-)waves appeared randomly, propagated within individual myocytes, were out-of-phase with adjacent myocytes, and often died-out. Systolic secondary Ca(2+-)elevations were synchronous within individual myocytes, appeared 188±30 ms after the action potential-upstroke, occurred during high cytosolic Ca(2+) (40%-60% of peak-Ca(2+)-transients), appeared first in small islands (0.5×0.5 mm(2)) that enlarged and spread throughout the epicardium. Synchronous systolic Ca(2+-)elevations preceded voltage-depolarizations (9.2±5 ms; n=5) and produced pronounced Spatial Heterogeneities of Ca(2+)-transient-durations and action potential-durations. Early afterdepolarizations originating from sites with the steepest gradients of membrane-potential propagated and initiated arrhythmias. Interestingly, more complex subcellular Ca(2+)-dynamics (multiple chaotic Ca(2+)-waves) occurred during arrhythmias. K201, a ryanodine receptor stabilizer, eliminated Ca(2+)-elevations and arrhythmias.
CONCLUSIONS: The results indicate that systolic and diastolic Ca(2+)-elevations emanate from sarcoplasmic reticulum Ca(2+)-release and systolic Ca(2+)-elevations are synchronous because of high cytosolic and luminal-sarcoplasmic reticulum Ca(2+), which overcomes source-sink mismatch to trigger arrhythmias in intact hearts.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  action potential; electrophysiology; high-resolution subcellular optical mapping; long QT syndrome; sarcoplasmic reticulum

Mesh:

Substances:

Year:  2015        PMID: 25722252      PMCID: PMC4472565          DOI: 10.1161/CIRCEP.114.002214

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  41 in total

1.  Effects of a novel cardioprotective drug, JTV-519, on membrane currents of guinea pig ventricular myocytes.

Authors:  J Kimura; M Kawahara; E Sakai; J Yatabe; H Nakanishi
Journal:  Jpn J Pharmacol       Date:  1999-03

Review 2.  Clinical practice. Long-QT syndrome.

Authors:  Dan M Roden
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

3.  Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel.

Authors:  M C Sanguinetti; M E Curran; A Zou; J Shen; P S Spector; D L Atkinson; M T Keating
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

4.  I(CaL) inhibition prevents arrhythmogenic Ca(2+) waves caused by abnormal Ca(2+) sensitivity of RyR or SR Ca(2+) accumulation.

Authors:  Mathis K Stokke; Nils Tovsrud; William E Louch; Leiv Øyehaug; Karina Hougen; Ole M Sejersted; Fredrik Swift; Ivar Sjaastad
Journal:  Cardiovasc Res       Date:  2013-02-14       Impact factor: 10.787

5.  Ca2+ stores regulate ryanodine receptor Ca2+ release channels via luminal and cytosolic Ca2+ sites.

Authors:  Derek R Laver
Journal:  Biophys J       Date:  2007-03-09       Impact factor: 4.033

6.  Modulation of cytosolic and intra-sarcoplasmic reticulum calcium waves by calsequestrin in rat cardiac myocytes.

Authors:  Zuzana Kubalova; Inna Györke; Radmila Terentyeva; Serge Viatchenko-Karpinski; Dmitry Terentyev; Simon C Williams; Sandor Györke
Journal:  J Physiol       Date:  2004-10-14       Impact factor: 5.182

Review 7.  Genetics of acquired long QT syndrome.

Authors:  Dan M Roden; Prakash C Viswanathan
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

8.  Bradycardia alters Ca(2+) dynamics enhancing dispersion of repolarization and arrhythmia risk.

Authors:  Jong J Kim; Jan Němec; Rita Papp; Robert Strongin; Jonathan J Abramson; Guy Salama
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-11       Impact factor: 4.733

9.  Sex, age, and regional differences in L-type calcium current are important determinants of arrhythmia phenotype in rabbit hearts with drug-induced long QT type 2.

Authors:  Carl Sims; Steven Reisenweber; Prakash C Viswanathan; Bum-Rak Choi; William H Walker; Guy Salama
Journal:  Circ Res       Date:  2008-04-24       Impact factor: 17.367

10.  K201 modulates excitation-contraction coupling and spontaneous Ca2+ release in normal adult rabbit ventricular cardiomyocytes.

Authors:  C M Loughrey; N Otani; T Seidler; M A Craig; R Matsuda; N Kaneko; G L Smith
Journal:  Cardiovasc Res       Date:  2007-06-22       Impact factor: 10.787

View more
  13 in total

1.  Evaluation of beat-to-beat ventricular repolarization lability from standard 12-lead ECG during acute myocardial ischemia.

Authors:  Salah S Al-Zaiti; Mohammad Alrawashdeh; Christian Martin-Gill; Clifton Callaway; David Mortara; Jan Nemec
Journal:  J Electrocardiol       Date:  2017-08-10       Impact factor: 1.438

2.  Spontaneous initiation of premature ventricular complexes and arrhythmias in type 2 long QT syndrome.

Authors:  Xiaodong Huang; Tae Yun Kim; Gideon Koren; Bum-Rak Choi; Zhilin Qu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-10-07       Impact factor: 4.733

3.  Dual Vm/Ca imaging of premature ventricular contractions: bridging the gap of anatomical scales.

Authors:  Crystal M Ripplinger; Igor R Efimov
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-06

Review 4.  The link between abnormal calcium handling and electrical instability in acquired long QT syndrome--Does calcium precipitate arrhythmic storms?

Authors:  Jan Němec; Jong J Kim; Guy Salama
Journal:  Prog Biophys Mol Biol       Date:  2015-11-26       Impact factor: 3.667

5.  Balance Between Rapid Delayed Rectifier K+ Current and Late Na+ Current on Ventricular Repolarization: An Effective Antiarrhythmic Target?

Authors:  Bence Hegyi; Ye Chen-Izu; Leighton T Izu; Sridharan Rajamani; Luiz Belardinelli; Donald M Bers; Tamás Bányász
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-03-23

6.  Global Optimization of Ventricular Myocyte Model to Multi-Variable Objective Improves Predictions of Drug-Induced Torsades de Pointes.

Authors:  Trine Krogh-Madsen; Anna F Jacobson; Francis A Ortega; David J Christini
Journal:  Front Physiol       Date:  2017-12-19       Impact factor: 4.566

7.  Genomic upregulation of cardiac Cav1.2α and NCX1 by estrogen in women.

Authors:  Rita Papp; Glenna C L Bett; Agnieszka Lis; Randall L Rasmusson; István Baczkó; András Varró; Guy Salama
Journal:  Biol Sex Differ       Date:  2017-08-14       Impact factor: 5.027

8.  Autonomic conflict exacerbates long QT associated ventricular arrhythmias.

Authors:  James Winter; Michael J Tipton; Michael J Shattock
Journal:  J Mol Cell Cardiol       Date:  2018-02-02       Impact factor: 5.000

9.  QT Adaptation and Intrinsic QT Variability in Congenital Long QT Syndrome.

Authors:  Srikanth Seethala; Prabhpreet Singh; Vladimir Shusterman; Margareth Ribe; Kristina H Haugaa; Jan Němec
Journal:  J Am Heart Assoc       Date:  2015-12-16       Impact factor: 5.501

10.  R-From-T as a Common Mechanism of Arrhythmia Initiation in Long QT Syndromes.

Authors:  Michael B Liu; Nele Vandersickel; Alexander V Panfilov; Zhilin Qu
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.